CN103494897A - Traditional Chinese medicine for treating chronic hepatitis - Google Patents
Traditional Chinese medicine for treating chronic hepatitis Download PDFInfo
- Publication number
- CN103494897A CN103494897A CN201310460805.XA CN201310460805A CN103494897A CN 103494897 A CN103494897 A CN 103494897A CN 201310460805 A CN201310460805 A CN 201310460805A CN 103494897 A CN103494897 A CN 103494897A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- chronic hepatitis
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating chronic hepatitis. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 20-30 parts of felwort, 25-35 parts of astragalus, 20-30 parts of abrus cantoniensis hance, 10-18 parts of Radix Scutellariae, 8-15 parts of fructus schisandrae, 5-15 parts of radix paeoniae rubra, 10-16 parts of salvia miltiorrhiz, 4-8 parts of costus root, 8-15 parts of lucid ganoderma, 3-8 parts of herba epimedii and 4-12 parts of Semen Cuscutae. According to the traditional Chinese medicine for treating chronic hepatitis, felwort, astragalus and abrus cantoniensis hance are taken as main medicines and matched with other adjuvants; the main medicines and adjuvants influence one another and act synergistically so as to achieve good functions of clearing away heat, detoxing and removing dampness, activating blood, dissipating blood stasis, nourishing yin and benefiting qi, has good curative effect on chronic hepatitis and hepatitis B, and is simple in raw materials, low in cost and convenient to take.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of chronic hepatitis.
Background technology
Hepatitis, typically refer to by multiple paathogenic factor--as virus, antibacterial, parasite, chemical toxicant, medicine and poisonous substance, ethanol etc., the infringement liver, make the cell of liver be damaged, the function of liver suffers damage, it can cause a series of malaise symptoms of health pearl, and liver function index is abnormal.Hepatitis is divided acute and chronic hepatitis.The pathological changes of various hepatitis is mainly at liver, and some similar clinical manifestations are arranged, and outside nosetiology, serology, damage mechanism, clinical process and prognosis, liver, often there is obvious difference the aspect such as infringement.The medicine for the treatment of chronic hepatitis is numerous at present, for example publication number is: CN101152540, name are called the Chinese invention patent application of " Chinese medicine for the treatment of chronic hepatitis ", this invention belongs to the Chinese medicine for the treatment of hepatitis, its composition: Radix Codonopsis, each 30 grams of Radix Salviae Miltiorrhizae, the Rhizoma Atractylodis Macrocephalae, Herba Epimedii, Radix Bupleuri, Radix Curcumae, each 15 grams of Rhizoma Paridis, Poria, Rhizoma Alismatis, Spica Prunellae, each 20 grams of Rhizoma Polygoni Cuspidati, Radix Glycyrrhizae 6 grams, the Radix Paeoniae Alba 12 grams; Auxiliary prescription: uncomfortable in chest being insomnia adds Pericarpium Citri Reticulatae, each 10 grams of Rhizoma Pinelliae Preparatum; Hypochondriac pain very adds Flos jasmini, each 12 grams of Radix Malloti Apelitae; Jaundice is removed Herba Epimedii, adds Herba Artemisiae Scopariae, each 10 grams of Herba Abri.The material that makes up a prescription in prescription is all used natural Chinese herbal medicine, then adds that traditional concocting method is made, and material is easily got, and formula and preparation method are simple, prepare consumption cost cheap.Take therapeutic effect good, drug price is cheap, can adapt to especially the people that live in away from small towns, outlying village and use, cheap to people's medical expense of suffering from the chronic hepatitis disease, solved because family income is low, living in penury, locality lacks the problem that medical condition is cured the disease.But the compatibility of this medicine is comparatively complicated.
Summary of the invention
The technical problem to be solved in the present invention is to provide that a kind of compatibility is comparatively simple, the Chinese medicine of safe without toxic side effect, eutherapeutic treatment chronic hepatitis.
For solving the problems of the technologies described above, the present invention by the following technical solutions:
The present invention treats the Chinese medicine of chronic hepatitis, is to be made by the raw material of following weight proportioning:
Radix Gentianae 20～30, the Radix Astragali 25～35, Herba Abri 20～30, Radix Scutellariae 10～18, Fructus Schisandrae Chinensis 8～15, Radix Paeoniae Rubra 5～15, Radix Salviae Miltiorrhizae 10～16, Radix Aucklandiae (Radix Vladimiriae) 4～8, Ganoderma 8～15, Herba Epimedii 3～8, Semen Cuscutae 4～12.
The preferred weight proportioning of each raw material is:
Radix Gentianae 22～28, the Radix Astragali 28～32, Herba Abri 22～28, Radix Scutellariae 12～16, Fructus Schisandrae Chinensis 9～13, Radix Paeoniae Rubra 8～12, Radix Salviae Miltiorrhizae 12～14, Radix Aucklandiae (Radix Vladimiriae) 5～7, Ganoderma 10～13, Herba Epimedii 4～7, Semen Cuscutae 6～10.
The optimum weight proportioning of each raw material is:
Radix Gentianae 25, the Radix Astragali 30, Herba Abri 26, Radix Scutellariae 14, Fructus Schisandrae Chinensis 12, Radix Paeoniae Rubra 10, Radix Salviae Miltiorrhizae 13, Radix Aucklandiae (Radix Vladimiriae) 6, Ganoderma 12, Herba Epimedii 5, Semen Cuscutae 8.
The preparation method that the present invention treats the Chinese medicine of chronic hepatitis is: take by weight ratio raw material Radix Gentianae, the Radix Astragali, Herba Abri, Radix Scutellariae, Fructus Schisandrae Chinensis, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Radix Aucklandiae (Radix Vladimiriae), Ganoderma, Herba Epimedii, Semen Cuscutae, add the decocting of 6～10 times of raw material weights to boil, the water rear slow fire that boils boils 40～60 minutes, leach medicinal liquid, obtain.
The instructions of taking that the present invention treats the Chinese medicine of chronic hepatitis is: oral, every day twice, each serving 200～300 grams, take 4～6 months.
The Chinese medicine that the present invention treats chronic hepatitis be take Radix Gentianae, the Radix Astragali and Herba Abri as principal agent, other accessory drugs of arranging in pairs or groups, they influence each other, synergism, thereby play good clearing heat, detoxicating, dispelling dampness, blood circulation promoting and blood stasis dispelling, enriching yin boost qi effect, chronic hepatitis and hepatitis B are had to good curative effect, and its raw material is simple, with low cost, taking convenience.
The specific embodiment
Below with embodiment, the invention will be further described, but the present invention is not limited to these embodiment.
Below umber described in each embodiment be weight portion.
Embodiment 1
The drug weight proportioning:
20 parts of Radix Gentianaes, 25 parts of the Radixs Astragali, 20 parts of Herba Abris, 10 parts of Radix Scutellariaes, 8 parts of Fructus Schisandrae Chinensis, 5 parts of Radix Paeoniae Rubras, 10 parts of Radix Salviae Miltiorrhizaes, 4 parts of Radix Aucklandiae (Radix Vladimiriae), 8 parts of Ganodermas, 3 parts of Herba Epimedii, 4 parts of Semen Cuscutae.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 6 times of raw material weights to boil, the water rear slow fire that boils boils 40 minutes, leaches medicinal liquid, obtains.
Embodiment 2
The drug weight proportioning:
30 parts of Radix Gentianaes, 35 parts of the Radixs Astragali, 30 parts of Herba Abris, 18 parts of Radix Scutellariaes, 15 parts of Fructus Schisandrae Chinensis, 15 parts of Radix Paeoniae Rubras, 16 parts of Radix Salviae Miltiorrhizaes, 8 parts of Radix Aucklandiae (Radix Vladimiriae), 15 parts of Ganodermas, 8 parts of Herba Epimedii, 12 parts of Semen Cuscutae.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 10 times of raw material weights to boil, the water rear slow fire that boils boils 60 minutes, leaches medicinal liquid, obtains.
Embodiment 3
The drug weight proportioning:
25 parts of Radix Gentianaes, 30 parts of the Radixs Astragali, 26 parts of Herba Abris, 14 parts of Radix Scutellariaes, 12 parts of Fructus Schisandrae Chinensis, 10 parts of Radix Paeoniae Rubras, 13 parts of Radix Salviae Miltiorrhizaes, 6 parts of Radix Aucklandiae (Radix Vladimiriae), 12 parts of Ganodermas, 5 parts of Herba Epimedii, 8 parts of Semen Cuscutae.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 8 times of raw material weights to boil, the water rear slow fire that boils boils 50 minutes, leaches medicinal liquid, obtains.
Experimental example:
Below example is further set forth the beneficial effect that the present invention treats the Chinese medicine of chronic hepatitis by experiment.
1, experiment crowd:
Be divided into A, two experimental grouies of B:
A group: chronic hepatitis man patient 100 examples; 30～60 years old age.
B group: chronic hepatitis female patient 100 examples; 30～60 years old age.
2, drug administration method:
Chinese medicine every day of the treatment chronic hepatitis that the oral embodiment of the present invention 3 makes 2 times, each serving 300 grams, serve on 5 months.
3, efficacy evaluation:
(1) invalid: with take medicine before compare, without significant change.
(2) produce effects: therapeutic effect is obvious.
4, therapeutic effect:
Claims (3)
1. a Chinese medicine for the treatment of chronic hepatitis it is characterized in that being made by the raw material of following weight proportioning:
Radix Gentianae 20～30, the Radix Astragali 25～35, Herba Abri 20～30, Radix Scutellariae 10～18, Fructus Schisandrae Chinensis 8～15, Radix Paeoniae Rubra 5～15, Radix Salviae Miltiorrhizae 10～16, Radix Aucklandiae (Radix Vladimiriae) 4～8, Ganoderma 8～15, Herba Epimedii 3～8, Semen Cuscutae 4～12.
2. the Chinese medicine for the treatment of chronic hepatitis according to claim 1 is characterized in that the weight proportion of each raw material is:
Radix Gentianae 22～28, the Radix Astragali 28～32, Herba Abri 22～28, Radix Scutellariae 12～16, Fructus Schisandrae Chinensis 9～13, Radix Paeoniae Rubra 8～12, Radix Salviae Miltiorrhizae 12～14, Radix Aucklandiae (Radix Vladimiriae) 5～7, Ganoderma 10～13, Herba Epimedii 4～7, Semen Cuscutae 6～10.
3. the Chinese medicine for the treatment of chronic hepatitis according to claim 2 is characterized in that the weight proportion of each raw material is:
Radix Gentianae 25, the Radix Astragali 30, Herba Abri 26, Radix Scutellariae 14, Fructus Schisandrae Chinensis 12, Radix Paeoniae Rubra 10, Radix Salviae Miltiorrhizae 13, Radix Aucklandiae (Radix Vladimiriae) 6, Ganoderma 12, Herba Epimedii 5, Semen Cuscutae 8.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310460805.XA CN103494897A (en) | 2013-09-30 | 2013-09-30 | Traditional Chinese medicine for treating chronic hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310460805.XA CN103494897A (en) | 2013-09-30 | 2013-09-30 | Traditional Chinese medicine for treating chronic hepatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103494897A true CN103494897A (en) | 2014-01-08 |
Family
ID=49860220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310460805.XA Pending CN103494897A (en) | 2013-09-30 | 2013-09-30 | Traditional Chinese medicine for treating chronic hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103494897A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105106837A (en) * | 2015-08-28 | 2015-12-02 | 安徽省颍上县中医院 | Traditional Chinese medicine combination for treating viral hepatitis |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1363392A (en) * | 2001-08-07 | 2002-08-14 | 东营市恒仁堂生物工程有限责任公司 | Process for preparing instant particles for treating hepatitis B |
| CN1679901A (en) * | 2005-01-21 | 2005-10-12 | 叶耀良 | Compound preparation of Jianganling for liver and its making method |
| CN1726999A (en) * | 2004-09-10 | 2006-02-01 | 石药集团中奇制药技术（石家庄）有限公司 | Medication for treating hepatic fibrosis, and preparation method |
| WO2007059250A2 (en) * | 2005-11-15 | 2007-05-24 | Access Business Group International Llc | Plant-based formulations for improving liver health |
| CN1977888A (en) * | 2005-12-05 | 2007-06-13 | 黄振华 | Medicinal composition of baicalin, ganoderma lucidum and salvia miltrorrhiza |
| CN101933973A (en) * | 2009-07-02 | 2011-01-05 | 四川省中医药科学院 | Medicament composition for preventing and treating liver damage |
-
2013
- 2013-09-30 CN CN201310460805.XA patent/CN103494897A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1363392A (en) * | 2001-08-07 | 2002-08-14 | 东营市恒仁堂生物工程有限责任公司 | Process for preparing instant particles for treating hepatitis B |
| CN1726999A (en) * | 2004-09-10 | 2006-02-01 | 石药集团中奇制药技术（石家庄）有限公司 | Medication for treating hepatic fibrosis, and preparation method |
| CN1679901A (en) * | 2005-01-21 | 2005-10-12 | 叶耀良 | Compound preparation of Jianganling for liver and its making method |
| WO2007059250A2 (en) * | 2005-11-15 | 2007-05-24 | Access Business Group International Llc | Plant-based formulations for improving liver health |
| CN1977888A (en) * | 2005-12-05 | 2007-06-13 | 黄振华 | Medicinal composition of baicalin, ganoderma lucidum and salvia miltrorrhiza |
| CN101933973A (en) * | 2009-07-02 | 2011-01-05 | 四川省中医药科学院 | Medicament composition for preventing and treating liver damage |
Non-Patent Citations (3)
| Title |
|---|
| 孙立: "彭胜权教授对慢性乙型肝炎的辨治及调护经验", 《陕西中医》, vol. 27, no. 1, 31 December 2006 (2006-12-31), pages 79 - 81 * |
| 沈原: "《健康宝典》", 30 September 2007, article "鸡骨草治急、慢性肝炎", pages: 173 * |
| 胡克菲等: "复方软肝颗粒质量标准研究", 《中成药》, vol. 31, no. 3, 31 March 2009 (2009-03-31) * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105106837A (en) * | 2015-08-28 | 2015-12-02 | 安徽省颍上县中医院 | Traditional Chinese medicine combination for treating viral hepatitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463404B (en) | Traditional Chinese medicine composition for treating liver and kidney yin deficiency | |
| CN101934052B (en) | Medicament for treating facial chloasma and preparation method thereof | |
| CN101422579B (en) | Traditional Chinese medicine preparation for treating oral ulcer | |
| CN104001035A (en) | Trichosanthis Radix and Radix Puerariae-containing traditional Chinese medicinal preparation for treating type 2 diabetes mellitus | |
| CN102872381A (en) | Chinese medicinal composition for treating epidemic parotitis | |
| CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
| CN101856487A (en) | Chinese medicament for treating insomnia | |
| CN103211990A (en) | Chinese medicinal composition for treating oral ulcer | |
| CN103211962A (en) | Chinese medicinal composition for treating anhypnia | |
| CN103100035B (en) | Traditional Chinese medicine (TCM) decoction for treating globus hysteriocus | |
| CN100998825A (en) | Oral Chinese medicine for treating yin blood insufficiency type virus myocarditis | |
| CN104306876A (en) | Traditional Chinese medicinal composition for treating anemopyretic cold | |
| CN103721082A (en) | Traditional Chinese medicinal composition for treating scapulohumeral periarthritis | |
| CN101152540A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN103479835A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN103071079B (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
| CN102631450A (en) | Traditional Chinese medicine (TCM) decoction for treating wind-cold type common cold | |
| CN103494897A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN104127602A (en) | Traditional Chinese medicine for treating fatty liver | |
| CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN104435545A (en) | Traditional Chinese medicine preparation for treating leucopenia caused by benzene poisoning | |
| CN103479815A (en) | Traditional Chinese medicine for treating urinary tract infection | |
| CN102727765A (en) | Internally-used medicine for treating aplastic anemia by nourishing yin and yang | |
| CN102166303B (en) | Chinese medicinal composition for treating chronic atrophic gastritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140108 |